文献速递脑血管病认知障碍与痴呆

脑健康评分与无症状中年人群脑健康神经影像标志物的关联

Brain Care Score and Neuroimaging Markers of Brain Health in Asymptomatic Middle-Age Persons.
PubMed 文献 · Neurology · 2024-07-25

这项英国生物银行前瞻性队列研究纳入34,509名无卒中或痴呆病史的中年人,评估脑健康评分(BCS)与白质损伤神经影像标志物的关联。基线BCS每增加5分,首次和重复影像评估的白质高信号体积分别降低25%和33%,各向异性分数分别升高18%和22%,平均弥散率分别降低9%和10%;基线BCS较高还与白质高信号进展和各向异性分数下降减少10%相关。

要点

  • 基线脑健康评分每增加5分,首次影像白质高信号体积降低25%(95%CI 23%-27%)
  • 基线脑健康评分每增加5分,重复影像白质高信号体积降低33%(95%CI 27%-39%)
  • 基线脑健康评分较高与白质高信号进展和各向异性分数下降减少10%(95%CI 3%-17%)相关

核心结论

  • 本研究将脑健康评分的影响扩展至临床沉默性脑血管病的神经影像标志物,结果提示改善脑健康评分可能是预防早期脑健康衰退的有价值干预措施。

研究设计与样本

  • 英国生物银行前瞻性队列研究,纳入34,509名无卒中或痴呆病史的参与者(平均年龄55岁,53%为女性),评估脑健康评分(范围0-21分,评分越高提示脑健康管理越好)与白质高信号体积、各向异性分数和平均弥散率及其进展的关联,采用校正年龄和性别的多变量线性回归分析。

主要发现

  • 基线脑健康评分每增加5分,首次影像评估的白质高信号体积降低25%(95%CI 23%-27%),重复影像评估降低33%(95%CI 27%-39%)。
  • 基线脑健康评分每增加5分,首次影像评估的各向异性分数升高18%(95%CI 16%-20%),重复影像评估升高22%(95%CI 15%-28%)。
  • 基线脑健康评分每增加5分,首次影像评估的平均弥散率降低9%(95%CI 7%-11%),重复影像评估降低10%(95%CI 4%-16%)。
  • 基线脑健康评分较高与白质高信号进展和各向异性分数下降减少10%(95%CI 3%-17%)相关。

临床怎么用

  • 原文未据此给出推荐,作者认为改善脑健康评分可能是预防早期脑健康衰退的有价值干预措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate associations between health-related behaviors as measured using the Brain Care Score (BCS) and neuroimaging markers of white matter injury. METHODS: This prospective cohort study in the UK Biobank assessed the BCS, a novel tool designed to empower patients to address 12 dementia and stroke risk factors. The BCS ranges from 0 to 21, with higher scores suggesting better brain care. Outcomes included white matter hyperintensities (WMH) volume, fractional anisotropy (FA), and mean diffusivity (MD) obtained during 2 imaging assessments, as well as their progression between assessments, using multivariable linear regression adjusted for age and sex. RESULTS: We included 34,509 participants (average age 55 years, 53% female) with no stroke or dementia history. At first and repeat imaging assessments, every 5-point increase in baseline BCS was linked to significantly lower WMH volumes (25% 95% CI [23%-27%] first, 33% [27%-39%] repeat) and higher FA (18% [16%-20%] first, 22% [15%-28%] repeat), with a decrease in MD (9% [7%-11%] first, 10% [4%-16%] repeat). In addition, a higher baseline BCS was associated with a 10% [3%-17%] reduction in WMH progression and FA decline over time. DISCUSSION: This study extends the impact of the BCS to neuroimaging markers of clinically silent cerebrovascular disease. Our results suggest that improving one's BCS could be a valuable intervention to prevent early brain health decline.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Rivier CA, Singh S, Senff J, et al. Brain Care Score and Neuroimaging Markers of Brain Health in Asymptomatic Middle-Age Persons. Neurology. 2024. PMID: 39052961. doi:10.1212/WNL.0000000000209687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。